PI-LAB-2026-041

PT-141, Independent Lab Report

PT-141 10mg · BioRegen Research

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 95.1% met the stated ≥95% claim. Content measured 98.4% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
95.1%

Label claimed ≥95%

Content accuracy
98.4%

9.84mg measured against 10mg claimed

Test recency
Current cycle

Published 5 months ago

Specimen PI-LAB-2026-041 Tested by Axiom Mass Spec Services 17 samples tested from this company Purity & Testing score 99/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 95% 95.1% Meets claim
Identity (MS) PT-141 Confirmed Matches label
Content 10 mg 9.84 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
A5416-26
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Purity, identity & content

Original laboratory report: PI-LAB-2026-041-report.pdf (document delivery arrives with the production storage backend)

More Tests, BioRegen Research

Tirzepatide (Compounded)
Purity 99.0% Verified
TB-500
Purity 99.2% Verified
CJC-1295
Purity 98.6% Verified

More Tests, PT-141

PT-141 NextGen Peptides
Purity 98.5% Verified
PT-141 Helix Research Supply
Purity 97.6% Discrepancy
PT-141 Quantum Peptide Group
Purity 96.8% Verified